Business Segments · Total Assets
Proprietary Products — Total Assets
West Pharmaceutical Services Proprietary Products — Total Assets decreased by 1.8% to $2.93B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.7%, from $2.63B to $2.93B.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026
Rolls up toTotal Assets
How to read this metric
An increase suggests capital expansion and investment in production capacity, whereas a decrease may indicate asset divestiture or improved capital efficiency.
Detailed definition
This represents the total book value of assets specifically allocated to the proprietary products business segment. It i...
Peer comparison
Similar to segment-specific asset reporting in diversified manufacturing or healthcare supply firms.
Metric ID:
wst_segment_proprietary_products_assetsHistorical Data
9 periods
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $2.15B | $2.58B | $2.63B | $2.62B | $2.63B | $2.83B | $2.99B | $2.99B | $2.93B |
| QoQ Change | — | +19.8% | +2.0% | -0.3% | +0.2% | +7.8% | +5.7% | -0.1% | -1.8% |
| YoY Change | — | +19.8% | +2.0% | -0.3% | — | — | — | +14.0% | +11.7% |
Range$2.15B – $2.99B
CAGR+16.7%
Avg YoY Growth+9.4%
Median YoY Growth+11.7%
Current Streak2 quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's proprietary products — total assets?
- West Pharmaceutical Services (WST) reported proprietary products — total assets of $2.93B in Q1 2026.
- How has West Pharmaceutical Services's proprietary products — total assets changed year-over-year?
- West Pharmaceutical Services's proprietary products — total assets increased by 11.7% year-over-year, from $2.63B to $2.93B.
- What does proprietary products — total assets mean?
- The total value of resources and equipment used to support the proprietary product business.